Stock Buybacks Plus

The large US companies that spent the most on buying back their own shares over the last twelve months, as a share of their market value, whose share count fell.

Who buys back the most, by sector

What these companies spent on their own shares over the last year, by sector.

Spent on buybacks over a year
$1.0T
Companies whose share count fell
292
of the 497 we follow
Median buyback yield
2.1%

What a company spent buying back its own shares over the last twelve months, as a share of its market value (the buyback yield), among the stocks we follow with full financials (the largest US companies) whose diluted share count fell over their last fiscal year.

Stock
1
CRM
CRMSalesforce
19.94%35.07B-1.8%175.85B
2
PYPL
PYPLPayPal Holdings
12.30%6.05B-6.8%49.21B
311.96%4.18B-1.5%34.94B
411.43%3.75B-2.4%32.81B
511.25%5.23B-2.2%46.51B
610.81%21.30B-2.0%197.10B
710.70%7.83B-13.8%73.16B
810.06%12.02B-4.2%119.48B
99.98%9.30B-5.1%93.12B
109.42%3.77B-9.0%39.99B
119.06%23.07B-0.6%254.59B
128.93%5.28B-3.5%59.18B
138.86%9.16B-11.9%103.41B
148.79%17.57B-2.3%199.90B
158.59%3.55B-7.8%41.33B
168.16%3.21B-3.2%39.34B
178.08%2.15B-2.6%26.62B
188.05%2.52B-6.4%31.30B
197.76%2.32B-1.1%29.87B
207.70%6.23B-1.5%80.98B

Lists are updated through every trading day.

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.